| CHRYSALIN Chrysalis BioTherapeutics, Inc.
90169585 09 Sep 2020 | on 17 Sep 2024
| Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI) | | | CHRYSALIS BIOTHERAPEUTICS Chrysalis BioTherapeutics, Inc.
90052179 14 Jul 2020 | on 17 Nov 2023 | Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI) | | 
